The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish Land Regulatory News (BLND)

Share Price Information for British Land (BLND)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 402.40
Bid: 401.60
Ask: 401.80
Change: -5.20 (-1.28%)
Spread: 0.20 (0.05%)
Open: 407.80
High: 408.20
Low: 401.40
Prev. Close: 407.60
BLND Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

26 Sep 2023 07:00

RNS Number : 5958N
British Land Co PLC
26 September 2023
 

BUSINESS UPDATE

 

British Land is publishing an update ahead of its Half Year results on 13 November 2023.

Simon Carter, CEO, said:

"I am pleased with the continued momentum in the business. Operationally we are seeing strong leasing activity which reflects the exceptional quality of our portfolio and has resulted in our recent upgrade of the expected ERV growth in retail parks. We have also strengthened our balance sheet in the period and continue to actively recycle capital with the disposal of non-core assets ahead of book value. Meta's surrender of our building at 1 Triton Square also enables us to accelerate our plans to reposition Regent's Place as London's premier Innovation and Life Sciences campus."

Operational performance

Achieved 1.2m sq ft of leasing across the portfolio in the first 5 months to 31 August 2023, 13.1% ahead of ERV, with a further 1.1m sq ft under offer, 17.4% ahead of ERV.

Campuses

- 262,000 sq ft of leasing completed 8.2% ahead of ERV, including 64,000 sq ft of Storey leasing, and a further 137,000 sq ft under offer, 10.5% ahead of ERV. In addition, we have 1.7m sq ft in negotiations as demand continues to gravitate to best in class space.

- Meta surrender of 1 Triton Square - one of the two buildings it has leased at Regent's Place - for £149m, received on 25 September 2023. Although this will result in a EPS dilution, post interest savings, of c.0.6p for the six months to March FY24 we are comfortable with current market expectations for FY24 due to better collection of historic COVID arrears than anticipated.

- Secured one of the UK's largest life science lettings this year, 48,000 sq ft of lab and office space at the Priestley Centre, Guildford to LGC, a leading global life science company.

Retail

- 980,000 sq ft of Retail leasing completed, 15.0% ahead of ERV, with a further 951,000 sq ft under offer, 19.4% ahead of ERV. This includes 511,000 sq ft of deals across Retail Parks, 15.3% ahead of ERV and 677,000 sq ft under offer at 19.4% above ERV.

- Upgraded Retail Park ERV growth guidance for FY24 from 2-4% to 3-5% as a result of strong leasing activity ahead of ERV.

Balance sheet and capital recycling

- Exchanged on the sale of an office and data centre portfolio for £125m, a NIY of 4.6%, which delivered an IRR of 8.2% per annum since acquisition in 2007.

- As a result of the Meta surrender and the disposal of the office and data centre portfolio, March 2023 LTV of 36.0% on a pro-forma basis would be 33.6%. 

- In August, Fitch affirmed British Land's senior unsecured credit rating at 'A' with Stable Outlook.

- Strong liquidity maintained, with £1.7bn of undrawn facilities and cash, with no requirement to refinance until early 2026.

 

-ENDS-

 

Investors:

Sandra Moura, British Land 07989 755 535

Media Enquiries:

Charlotte Whitley, British Land 07887 802 535

 

About British Land

Our portfolio of high quality UK commercial property is focused on London Campuses and Retail & London Urban Logistics. We own or manage a portfolio valued at £13.0bn (British Land share: £8.9bn) as at 31 March 2023 making us one of Europe's largest listed real estate investment companies.

We create Places People Prefer, delivering the best, most sustainable places for our customers and communities. Our strategy is to leverage our best in class platform and proven expertise in development, repositioning and active management, investing behind two key themes: Campuses and Retail & London Urban Logistics.

Our three Campuses at Broadgate, Paddington Central and Regent's Place are dynamic neighbourhoods, attracting growth customers and sectors, and offering some of the best connected, highest quality and most sustainable space in London. We are delivering our fourth Campus at Canada Water, where we have planning consent to deliver 5m sq ft of residential, commercial, retail and community space over 53 acres. Our Campuses account for 63% of our portfolio.

Retail & London Urban Logistics accounts for 37% of the portfolio and is focused on retail parks which are aligned to the growth of convenience, online and last mile fulfilment. We are complementing this with urban logistics primarily in London, focused on development-led opportunities.

Sustainability is embedded throughout our business. Our approach is focused on three key pillars where British Land can create the most benefit: Greener Spaces, making our whole portfolio net zero carbon by 2030, Thriving Places, partnering to grow social value and wellbeing in the communities where we operate and Responsible Choices, advocating responsible business practices across British Land and throughout our supply chain, and maintaining robust governance structures.

Further details can be found on the British Land website at www.britishland.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFIIASIEFIV
Date   Source Headline
16th Jun 202311:00 amRNSDirector/PDMR Shareholding
15th Jun 202312:00 pmRNSDirector/PDMR Shareholding
14th Jun 202312:00 pmRNSHolding(s) in Company
13th Jun 202312:00 pmRNSHolding(s) in Company
9th Jun 20233:54 pmRNSAnnual Financial Report
9th Jun 20232:00 pmRNSHolding(s) in Company
8th Jun 20232:00 pmRNSHolding(s) in Company
2nd Jun 202310:00 amRNSDirector/PDMR Shareholding
31st May 20233:00 pmRNSTotal Voting Rights
30th May 20237:00 amRNSDirector/PDMR Shareholding
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20232:00 pmRNSDirector/PDMR Shareholding
19th May 20232:00 pmRNSHolding(s) in Company
17th May 20237:00 amRNSFinal Results
16th May 202312:00 pmRNSDirector/PDMR Shareholding
5th May 20233:00 pmRNSHolding(s) in Company
28th Apr 20231:29 pmRNSTotal Voting Rights
18th Apr 20232:15 pmRNSDirector/PDMR Shareholding
11th Apr 202311:00 amRNSBlock listing Interim Review
11th Apr 202310:30 amRNSDirector/PDMR Shareholding
3rd Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 202310:00 amRNSHolding(s) in Company
31st Mar 20239:00 amRNSTotal Voting Rights
30th Mar 20233:53 pmRNSHolding(s) in Company
29th Mar 202312:00 pmRNSHolding(s) in Company
16th Mar 20233:30 pmRNSDirector/PDMR Shareholding
10th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Feb 20232:00 pmRNSTotal Voting Rights
15th Feb 20234:00 pmRNSDirector/PDMR Shareholding
31st Jan 202312:57 pmRNSTotal Voting Rights
17th Jan 20231:56 pmRNSDirector/PDMR Shareholding
10th Jan 202312:00 pmRNSDirector/PDMR Shareholding
5th Jan 20232:00 pmRNSDirector/PDMR Shareholding
30th Dec 20229:55 amRNSTotal Voting Rights
16th Dec 20222:30 pmRNSDirector/PDMR Shareholding
30th Nov 20223:00 pmRNSTotal Voting Rights
18th Nov 20227:10 amRNSDirector Declaration
16th Nov 20227:00 amRNSHalf-year Report
15th Nov 202212:00 pmRNSDirector/PDMR Shareholding
31st Oct 20223:52 pmRNSDirector/PDMR Shareholding
31st Oct 20223:31 pmRNSTotal Voting Rights
18th Oct 20222:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:00 pmRNSBlock listing Interim Review
30th Sep 202212:00 pmRNSTotal Voting Rights
16th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 20223:30 pmRNSDirector/PDMR Shareholding
31st Aug 20221:00 pmRNSTotal Voting Rights
16th Aug 20222:00 pmRNSDirector/PDMR Shareholding
4th Aug 202212:00 pmRNSDirector/PDMR Shareholding
29th Jul 20222:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.